60 degrees pharmaceuticals, Inc.(SXTP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

SXTP 60 degrees pharmaceuticals, Inc.

Pre-Mkt 03-20 08:29:39 EDT

1.93

-0.19

-8.96%

盘前1.96

+0.03+1.55%

08:06 EDT

High2.11	Low1.82	Vol294.82K
Open2.11	D1 Closing2.12	Amplitude13.68%
Mkt Cap2.48M	Tradable Cap2.20M	Total Shares1.29M
T/O566.54K	T/O Rate25.85%	Tradable Shares1.14M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"SXTP","market":"US","secType":"STK","nameCN":"60 degrees pharmaceuticals, Inc.","latestPrice":1.93,"timestamp":1773950400000,"preClose":2.12,"halted":0,"volume":294818,"hourTrading":{"tag":"盘前","latestPrice":1.96,"preClose":1.93,"latestTime":"08:06 EDT","volume":636,"amount":1229.6673948,"timestamp":1774008414845,"change":0.03,"changeRate":0.015544,"amplitude":0.036425},"delay":0,"changeRate":-0.08962264150943404,"floatShares":1140600,"shares":1287200,"eps":-18.291412,"marketStatus":"Pre-Mkt","change":-0.19,"latestTime":"03-20 08:29:39 EDT","open":2.11,"high":2.11,"low":1.82,"amount":566541.137152,"amplitude":0.136792,"askPrice":2.21,"askSize":100,"bidPrice":1.91,"bidSize":369,"shortable":0,"etf":0,"ttmEps":-18.291412,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774013400000},"marketStatusCode":1,"adr":0,"listingDate":1686801600000,"exchange":"NASDAQ","adjPreClose":1.93,"preHourTrading":{"tag":"盘前","latestPrice":1.96,"preClose":1.93,"latestTime":"08:06 EDT","volume":636,"amount":1229.6673948,"timestamp":1774008414845,"change":0.03,"changeRate":0.015544,"amplitude":0.036425},"postHourTrading":{"tag":"盘后","latestPrice":1.99,"preClose":1.93,"latestTime":"19:43 EDT","volume":2278,"amount":4373.2905,"timestamp":1773963818107,"change":0.06,"changeRate":0.031088,"amplitude":0.042124},"volumeRatio":0.20535629579206355},"requestUrl":"/m/hq/s/SXTP","defaultTab":"news","newsList":[{"id":"2620253573","title":"BRIEF-60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut Extract","url":"https://stock-news.laohu8.com/highlight/detail?id=2620253573","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620253573?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:06","pubTimestamp":1773835600,"startTime":"0","endTime":"0","summary":"BRIEF-60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (Ndin) With FDA For Australian Chestnut ExtractMarch 18 (Reuters) - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nFWN40615P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTPW","BK4007","SXTP"],"gpt_icon":0},{"id":"2619214566","title":"60 Degrees Pharmaceuticals Updates Legal Opinion for ATM Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2619214566","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619214566?lang=en_us&edition=fundamental","pubTime":"2026-03-14 05:51","pubTimestamp":1773438707,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) has issued an update. On March 13, 2026, 60 Degrees Pharmaceuticals, Inc. filed an updated legal opini...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-updates-legal-opinion-for-atm-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-updates-legal-opinion-for-atm-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2619906781","title":"What's Going On With 60 Degrees Pharmaceuticals On Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2619906781","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619906781?lang=en_us&edition=fundamental","pubTime":"2026-03-13 21:11","pubTimestamp":1773407460,"startTime":"0","endTime":"0","summary":"60 Degrees Pharma shares fall premarket after a huge rally as its babesiosis trial reports a 100% cure rate with tafenoquine treatment.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/03/13/Pathway-Of-Infection.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/03/13/Pathway-Of-Infection.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/26/03/51239146/whats-going-on-with-60-degrees-pharmaceuticals-on-friday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/26/03/51239146/whats-going-on-with-60-degrees-pharmaceuticals-on-friday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2618137401","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:55 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2618137401","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618137401?lang=en_us&edition=fundamental","pubTime":"2026-03-12 21:55","pubTimestamp":1773323756,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 09:55 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nAQN2LPYU2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2618533941","title":"60 Degrees Pharmaceuticals reports 100% babesiosis cure rate in tafenoquine expanded access trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2618533941","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618533941?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:24","pubTimestamp":1773228265,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals reports 100% babesiosis cure rate in tafenoquine expanded access trial               60 Degrees Pharmaceuticals reported that all three enrolled patients in its open-label e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL46ST3m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014013.SGD","LU0314104364.USD","SXTP","BK4007","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD","BK4112","LU2210150020.SGD","SG9999014039.USD","BK4588","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","NDAQ"],"gpt_icon":0},{"id":"2618294130","title":"60 Degrees Pharmaceuticals Announces All Patients Cured of Babesiosis After Tafenoquine Treatment in Expanded Use Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2618294130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618294130?lang=en_us&edition=fundamental","pubTime":"2026-03-11 19:24","pubTimestamp":1773228240,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nTUA3LWNBQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SXTPW","SXTP","BK4007"],"gpt_icon":0},{"id":"2610220789","title":"BRIEF-60 Degrees Pharmaceuticals Company Regained Compliance With Nasdaq Minimum Bid Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2610220789","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610220789?lang=en_us&edition=fundamental","pubTime":"2026-02-12 22:32","pubTimestamp":1770906749,"startTime":"0","endTime":"0","summary":"BRIEF-60 Degrees Pharmaceuticals Company Regained Compliance With Nasdaq Minimum Bid Price Feb 12  - 60 Degrees Pharmaceuticals Inc SXTP.O:60 DEGREES PHARMACEUTICALS INC - COMPANY REGAINED COMPLIANCE WITH NASDAQ MINIMUM BID PRICE - SEC FILINGSource text: [ID:n0001213900-26-015239]Further company coverage: SXTP.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nFWN3Z81H1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2610392217","title":"60 Degrees Pharmaceuticals Regains Nasdaq Listing Compliance Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2610392217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610392217?lang=en_us&edition=fundamental","pubTime":"2026-02-12 22:17","pubTimestamp":1770905851,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) just unveiled an update. On January 20, 2026, 60 Degrees Pharmaceuticals received notice from Nasdaq t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-regains-nasdaq-listing-compliance-status?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-regains-nasdaq-listing-compliance-status?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SXTP","NQmain","BK4007"],"gpt_icon":0},{"id":"2608861024","title":"60 Degrees expands access to Arakoda with GoodRx partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2608861024","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608861024?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:21","pubTimestamp":1770038466,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals (SXTP) announced a partnership with GoodRx (GDRX) to offer eligible consumers savings of up to 30% on Arakoda. Starting ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-expands-access-to-arakoda-with-goodrx-partnership-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-expands-access-to-arakoda-with-goodrx-partnership-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","SXTP","GDRX","BK4007"],"gpt_icon":0},{"id":"2608861313","title":"60 Degrees Pharmaceuticals Partners with GoodRx to Offer Savings on Malaria Drug ARAKODA","url":"https://stock-news.laohu8.com/highlight/detail?id=2608861313","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608861313?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:02","pubTimestamp":1770037324,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc. has announced a partnership with GoodRx to expand access to its malaria prevention drug, ARAKODA . Through this collaboration, eligible consumers can receive prescription savings of up to 30% on ARAKODA at over 70,000 pharmacies nationwide. The partnership aims to lower out-of-pocket costs for travelers to malaria-endemic regions and broaden the reach of 60 Degrees Pharmaceuticals’ marketing efforts.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 60 Degrees Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire  on February 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDLc5yZdw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00B64PRP62.GBP","LU2210149790.SGD","LU2095319765.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4588","IE00BKPKM429.USD","NDAQ","IE00BGHQF748.EUR","GDRX","BK4007","SG9999014039.USD","BK4112","BK4585","SG9999014005.SGD","BK4167","SG9999014013.SGD","LU0314104364.USD","SXTP"],"gpt_icon":0},{"id":"2608690178","title":"60 Degrees Pharmaceuticals Expands Access to Arakoda® With GoodRx Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2608690178","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608690178?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:01","pubTimestamp":1770037260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nTUA8D4S5X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4167","SXTP","SXTPW","BK4007","GDRX"],"gpt_icon":0},{"id":"2606719063","title":"60 Degrees Pharmaceuticals Exercises License Option with Florida State University for Large-Scale Purification of Castanospermine for Non-Rx Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2606719063","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606719063?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:01","pubTimestamp":1769605260,"startTime":"0","endTime":"0","summary":"Company ready to commence regulatory process to secure access to U.S. market for Australian Chestnut Extract as a botanical product for non-prescription usesWASHINGTON, Jan.  28, 2026  (GLOBE NEWSWIRE","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/28/3227582/0/en/60-Degrees-Pharmaceuticals-Exercises-License-Option-with-Florida-State-University-for-Large-Scale-Purification-of-Castanospermine-for-Non-Rx-Use.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","STT","IE00B64PRP62.GBP","IE0034235188.USD","LU1894683348.USD","SXTP","IE00BGHQF748.EUR","BK4588","LU1883839398.USD","BK4007","LU0061475181.USD","IE00B3QW5Z07.USD","BK4585","LU1894683264.USD"],"gpt_icon":0},{"id":"2606077736","title":"60 Degrees Pharm Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2606077736","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606077736?lang=en_us&edition=fundamental","pubTime":"2026-01-28 00:45","pubTimestamp":1769532300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SXTP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 27, 2026 11:45 ET (16:45 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SXTP","BK4007"],"gpt_icon":0},{"id":"2606736762","title":"60 Degrees Pharmaceuticals target adjusted to $24 at H.C. Wainwright after split","url":"https://stock-news.laohu8.com/highlight/detail?id=2606736762","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606736762?lang=en_us&edition=fundamental","pubTime":"2026-01-28 00:30","pubTimestamp":1769531417,"startTime":"0","endTime":"0","summary":"H.C. Wainwright adjusted the firm’s price target on 60 Degrees Pharmaceuticals (SXTP) to $24 from $6 and keeps a Buy rating on the shares after acc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-target-adjusted-to-24-at-h-c-wainwright-after-split-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/60-degrees-pharmaceuticals-target-adjusted-to-24-at-h-c-wainwright-after-split-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2606104012","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2606104012","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606104012?lang=en_us&edition=fundamental","pubTime":"2026-01-26 20:46","pubTimestamp":1769431586,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals  shares were 32% lower pre-bell Monday, adding to losses from the previous session.Revolution Medicines  stock was down 20% after The Wall Street Journal reported over the weekend that Merck  has dropped its bid to acquire the oncology company over a disagreement on price.iOThree  shares were 16% lower after Friday's 4.5% gain.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2360032135.SGD","LU1116320901.HKD","BK4089","LU0965509101.SGD","LU2361045086.USD","LU1699723380.USD","IE00B4R5TH58.HKD","LU1162221912.USD","LU1934455863.HKD","LU0130102774.USD","LU2125154778.USD","LU0203347892.USD","SG9999015341.SGD","SG9999015358.SGD","LU0861579265.USD","LU0203345920.USD","IE00BJT1NW94.SGD","LU1201861249.SGD","LU0265550359.USD","LU0320765646.SGD","LU1037948541.HKD","LU1585245621.USD","LU1066053197.SGD","BK4534","IE00BLSP4239.USD","LU1291159041.SGD","IE000M9KFDE8.USD","BK4585","LU1093756325.SGD","SG9999001176.USD","LU0965509283.SGD","LU0985320562.USD","SG9999014567.USD","LU1929549753.HKD","BK4139","LU0289739699.SGD","LU1093756168.USD","LU1035773651.USD","LU0211331839.USD","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1941712348.USD","LU2125154935.USD","LU1066051498.USD","LU1430594728.SGD","LU0208291251.USD","LU1057294990.SGD","LU0965508806.USD","LU0980610538.SGD","BK4588","SG9999014575.USD","LU1023059063.AUD","SG9999002232.USD","LU2361044865.SGD","LU1934455194.USD","LU0266013472.USD","LU1989771016.USD","LU1934455277.USD","LU0477156953.USD","LU1061106388.HKD","LU2361044949.HKD","LU0070302665.USD","LU1983299246.USD","LU0006306889.USD","IE00BSNM7G36.USD","LU2106854487.HKD","LU0122379950.USD","LU0234572021.USD","SG9999001176.SGD","LU1066051811.HKD","LU0265550946.USD","LU0432979614.USD","SXTP","LU2023250843.SGD","BK4516","LU1941712264.USD","SG9999014542.SGD","LU0965509010.AUD","LU0106261372.USD","LU1989772923.USD","MRK","LU2461242641.AUD","LU2468319806.SGD","LU0130517989.USD","LU1989772840.SGD","BK4533","BK4007","IE00BJJMRZ35.SGD","SGXZ57979304.SGD","LU2112291526.USD","LU1116320737.USD","LU1917777945.USD","IE0002141913.USD","SG9999002224.SGD","IE00B2B36J28.USD","IE00B1BXHZ80.USD","LU0238689110.USD","LU0648001328.SGD","IE00BLSP4452.SGD","IE00BBT3K403.USD","LU1069347547.HKD","LU2023250504.SGD","LU0058720904.USD","LU1974910355.USD","IOTR","RVMD","SG9999013999.USD","BK4550","IE00BN8TJ469.HKD","LU0098860793.USD","LU2089984988.USD","SG9999001440.SGD","LU1037948897.HKD","LU2324357040.USD","SG9999014559.SGD","LU0320765489.SGD","BK4559","IE0009355771.USD","LU1066051225.USD"],"gpt_icon":0},{"id":"2606292307","title":"Nasdaq Moves to Delist 60 Degrees Pharmaceuticals Over Listing Rule Violation","url":"https://stock-news.laohu8.com/highlight/detail?id=2606292307","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606292307?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:27","pubTimestamp":1769412448,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals Inc. is facing potential delisting from the Nasdaq Capital Market after receiving notice from the Nasdaq Listing Qualifications Department. The company’s common stock failed to maintain a minimum bid price of $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550. Because the company conducted a 1-for-5 reverse stock split within the past year, it is not eligible for the standard 180-day compliance period and is subject to immediate delisting under Nasdaq Listing Rule 5810. Additionally, the company’s warrants are also subject to delisting, as their continued listing requires the underlying security to remain listed on Nasdaq. 60 Degrees Pharmaceuticals has appealed the decision, which temporarily stays the suspension of trading pending the outcome.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL8Vv5r5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SXTP"],"gpt_icon":0},{"id":"2605289815","title":"60 Degrees Pharmaceuticals Faces Immediate Nasdaq Delisting Appeal","url":"https://stock-news.laohu8.com/highlight/detail?id=2605289815","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605289815?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:54","pubTimestamp":1769208880,"startTime":"0","endTime":"0","summary":"An update from 60 Degrees Pharmaceuticals, Inc. ( ($SXTP) ) is now available. On January 20, 2026, 60 Degrees Pharmaceuticals, Inc. received a writ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-faces-immediate-nasdaq-delisting-appeal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/60-degrees-pharmaceuticals-faces-immediate-nasdaq-delisting-appeal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","NQmain","SXTP"],"gpt_icon":1},{"id":"2605411641","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2605411641","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605411641?lang=en_us&edition=fundamental","pubTime":"2026-01-23 02:58","pubTimestamp":1769108288,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals  reported Thursday a partnership with Runway Health to boost access to Arakoda for the prevention of malaria.Shares of 60 Degrees more than doubled as intraday trading volume soared to over 184.2 million from a daily average of about 71,000.Greenwich LifeSciences  announced Thursday that the US Food and Drug Administration approved the use of its first commercially manufactured lot of GP2 vials in the Flamingo-01 Phase 3 clinical trial for treating breast cancer relapses.Shares jumped 12% as intraday trading volume climbed to more than 4.5 million from a daily average of about 391,000.Creative Media & Community Trust  said Thursday it closed the sale of its lending division to PG FR Holding, an affiliate of Atlanta-based Peachtree Group, for $44.9 million, which is net of debt related to the 2023 securitization of certain loan receivables.Shares surged 28% as intraday trading volume soared to over 73.9 million from a daily average of roughly 2.64 million.Pric","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4194","BK4007","BK4223","SXTP","BK4139","GLSI","CMCT"],"gpt_icon":0},{"id":"2605151074","title":"Crude Oil Down 2%; Abbott Shares Fall Following Q4 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2605151074","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605151074?lang=en_us&edition=fundamental","pubTime":"2026-01-23 01:02","pubTimestamp":1769101334,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/market-summary/26/01/50075549/crude-oil-down-2-abbott-shares-fall-following-q4-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QYLD","LU0114720955.EUR","LU1691799644.USD","BK4585","IE0009355771.USD","LU1721429741.USD","QQQY","EGBN","IE00B2B36J28.USD","NQmain","JEPQ","BK4124","POET","LU0868494617.USD","QQQE","TQQQ","SXTP","LU2324357040.USD","USAW.SI","LU0289739699.SGD","TSYW.SI","LU1721429402.USD","IE00BJT1NW94.SGD","ABT","QYLG","SQQQ","QLD","GPIQ","LU0122379950.USD","SG9999004303.SGD","NVIW.SI","BK4592","IE00B4R5TH58.HKD","LU0234572021.USD","CMCT","QID","LU0266013472.USD","QQQJ","CISS","MNQmain","USJW.SI",".IXIC","PSQ","LU0058720904.USD","BK4533","LU2468319806.SGD","MTEN"],"gpt_icon":1},{"id":"2605269492","title":"Here’s Why 60 Degrees Pharmaceuticals Stock (SXTP) Rocketed Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2605269492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605269492?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:15","pubTimestamp":1769091344,"startTime":"0","endTime":"0","summary":"60 Degrees Pharmaceuticals stock rallied on Thursday after the company announced a collaboration with Runway Health.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/heres-why-60-degrees-pharmaceuticals-stock-sxtp-rocketed-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/heres-why-60-degrees-pharmaceuticals-stock-sxtp-rocketed-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","SXTP"],"gpt_icon":0}],"profile":{"websiteUrl":"http://60degreespharma.com","stockEarnings":[{"period":"1week","weight":-0.3368},{"period":"1month","weight":-0.3988},{"period":"3month","weight":-0.3643},{"period":"6month","weight":-0.6452},{"period":"1year","weight":-0.7575},{"period":"ytd","weight":-0.0508}],"compareEarnings":[{"period":"1week","weight":-0.0094},{"period":"1month","weight":-0.0338},{"period":"3month","weight":-0.0305},{"period":"6month","weight":-0.0059},{"period":"1year","weight":0.1634},{"period":"ytd","weight":-0.0324}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is based in Washington, District Of Columbia.","exchange":"NASDAQ","name":"60 degrees pharmaceuticals, Inc.","nameEN":"60 degrees pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"60 degrees pharmaceuticals, Inc.(SXTP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 60 degrees pharmaceuticals, Inc.(SXTP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"60 degrees pharmaceuticals, Inc.,SXTP,60 degrees pharmaceuticals, Inc.股票,60 degrees pharmaceuticals, Inc.股票老虎,60 degrees pharmaceuticals, Inc.股票老虎国际,60 degrees pharmaceuticals, Inc.行情,60 degrees pharmaceuticals, Inc.股票行情,60 degrees pharmaceuticals, Inc.股价,60 degrees pharmaceuticals, Inc.股市,60 degrees pharmaceuticals, Inc.股票价格,60 degrees pharmaceuticals, Inc.股票交易,60 degrees pharmaceuticals, Inc.股票购买,60 degrees pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"60 degrees pharmaceuticals, Inc.(SXTP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 60 degrees pharmaceuticals, Inc.(SXTP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}